Literature DB >> 902055

Arterial embolism in thyrotoxicosis with atrial fibrillation.

J S Staffurth, M C Gibberd, S N Fui.   

Abstract

In 262 patients with thyrotoxicosis and atrial fibrillation there were 26 episodes of arterial embolism (17 cerebral and nine elsewhere) in 21 patients. Twelve incidents occurred with active thyrotoxicosis, three on reversion to sinus rhythm, and 11 after the patients were euthyroid. This important complication is more common than is realised, and most patients should be put on prophylactic anticoagulants when first seen with atrial fibrillation.

Entities:  

Mesh:

Year:  1977        PMID: 902055      PMCID: PMC1631908          DOI: 10.1136/bmj.2.6088.688

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  12 in total

1.  RADIOIODINE THERAPY IN THYROTOXICOSIS; A REVIEW OF 908 CASES.

Authors:  E M MCGIRR; J A THOMSON; I P MURRAY
Journal:  Scott Med J       Date:  1964-12       Impact factor: 0.729

2.  The treatment of thyrocardiac disease with radioactive iodine.

Authors:  S SILVER; C DELIT; M ELLER
Journal:  Prog Cardiovasc Dis       Date:  1962-07       Impact factor: 8.194

3.  The nature and prognosis of heart disease in thyrotoxicosis. A review of 150 patients treated with 131 I.

Authors:  G SANDLER; G M WILSON
Journal:  Q J Med       Date:  1959-07

4.  An appreciation of mitral stenosis. I. Clinical features.

Authors:  P WOOD
Journal:  Br Med J       Date:  1954-05-08

5.  Vital Statistics.

Authors: 
Journal:  Br Med J       Date:  1959-01-24

6.  Auricular fibrillation in thyrotoxicosis, with special regard to the indication for quinidine therapy.

Authors:  A JERVELL
Journal:  Acta Med Scand Suppl       Date:  1952

7.  Responses to radioactive iodine therapy in hyperthyroidism, with special reference to cardiac problems.

Authors:  F MALOOF; E M CHAPMAN
Journal:  J Clin Endocrinol Metab       Date:  1951-11       Impact factor: 5.958

8.  Prognosis of atrial arrhythmias treated by electrical counter shock therapy. A three-year follow-up.

Authors:  C McCarthy; P J Varghese; D W Barritt
Journal:  Br Heart J       Date:  1969-07

9.  Atrial fibrillation in thyrotoxicosis treated with radioiodine.

Authors:  J S Staffurth; M C Gibberd; P J Hilton
Journal:  Postgrad Med J       Date:  1965-11       Impact factor: 2.401

10.  Prognosis of cerebral embolism.

Authors:  A B Carter
Journal:  Lancet       Date:  1965-09-11       Impact factor: 79.321

View more
  36 in total

Review 1.  Risk factors for stroke and primary prevention of stroke in atrial fibrillation.

Authors:  A Laupacis; D Singer; A Jacobsen; M Dunn; J Dalen; G Albers
Journal:  J Thromb Thrombolysis       Date:  1999-01       Impact factor: 2.300

Review 2.  Non-rheumatic atrial fibrillation: warfarin or aspirin for all?

Authors:  J Nolan; P Bloomfield
Journal:  Br Heart J       Date:  1992-12

3.  Heart failure in thyrotoxicosis, an approach to management.

Authors:  R P Choudhury; J MacDermot
Journal:  Br J Clin Pharmacol       Date:  1998-11       Impact factor: 4.335

Review 4.  Embolic risk in atrial fibrillation that arises from hyperthyroidism: review of the medical literature.

Authors:  Elie Traube; Neil L Coplan
Journal:  Tex Heart Inst J       Date:  2011

5.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  Circulation       Date:  2014-03-28       Impact factor: 29.690

6.  Graves' disease and atrial fibrillation: the case for even higher doses of therapeutic iodine-131.

Authors:  G R Scott; J C Forfar; A D Toft
Journal:  Br Med J (Clin Res Ed)       Date:  1984-08-18

Review 7.  Thyroid, hemostasis and thrombosis.

Authors:  F Marongiu; C Cauli; S Mariotti
Journal:  J Endocrinol Invest       Date:  2004-12       Impact factor: 4.256

8.  Thyrotoxicosis: changing trends in treatment.

Authors:  J Sheldon; D J Reid
Journal:  Ann R Coll Surg Engl       Date:  1986-09       Impact factor: 1.891

9.  Role of colestipol in the treatment of hyperthyroidism.

Authors:  P Hagag; H Nissenbaum; M Weiss
Journal:  J Endocrinol Invest       Date:  1998-12       Impact factor: 4.256

10.  Comparison of anticoagulant control among patients attending general practice and a hospital anticoagulant clinic.

Authors:  J P Pell; B McIver; P Stuart; D N Malone; J Alcock
Journal:  Br J Gen Pract       Date:  1993-04       Impact factor: 5.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.